Treatment by a Bispecific CD3xCD20 Antibody for Relapse/Refractory Lymphomas After CAR T-cells Therapy
The Lymphoma Academic Research Organisation
The Lymphoma Academic Research Organisation
University of Chicago
Institute of Hematology & Blood Diseases Hospital, China
H. Lee Moffitt Cancer Center and Research Institute
The Lymphoma Academic Research Organisation
Fondazione Italiana Linfomi - ETS
H. Lee Moffitt Cancer Center and Research Institute
Massachusetts General Hospital
Fondazione Italiana Linfomi - ETS
University of Arizona
Alliance for Clinical Trials in Oncology
Universität des Saarlandes
PrECOG, LLC.
Insel Gruppe AG, University Hospital Bern
Nantes University Hospital
University of Miami
Second Affiliated Hospital, School of Medicine, Zhejiang University
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Memorial Sloan Kettering Cancer Center
SCRI Development Innovations, LLC
Thomas Jefferson University
Washington University School of Medicine
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
University of California, Davis
Fred Hutchinson Cancer Center
The Lymphoma Academic Research Organisation
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Stanford University
Dana-Farber Cancer Institute
Stanford University
Memorial Sloan Kettering Cancer Center
University of Giessen
Calibr, a division of Scripps Research
University of Miami
Weill Medical College of Cornell University
City of Hope Medical Center
Northwestern University
City of Hope Medical Center
Roswell Park Cancer Institute
University Hospital Southampton NHS Foundation Trust
PrECOG, LLC.
University of Nebraska
University of Nebraska
M.D. Anderson Cancer Center
Stanford University